tiprankstipranks
Advertisement
Advertisement
Unicycive Therapeutics management to meet with Piper Sandler
PremiumThe FlyUnicycive Therapeutics management to meet with Piper Sandler
2M ago
Unicycive Therapeutics initiated with a Buy at WestPark Capital
Premium
The Fly
Unicycive Therapeutics initiated with a Buy at WestPark Capital
2M ago
De-Risked Regulatory Path and Commercial Readiness Underpin Buy Rating on Unicycive and Lead Asset OLC
Premium
Ratings
De-Risked Regulatory Path and Commercial Readiness Underpin Buy Rating on Unicycive and Lead Asset OLC
3M ago
Unicycive Therapeutics Doubles Stock Sale Agreement
PremiumCompany AnnouncementsUnicycive Therapeutics Doubles Stock Sale Agreement
5M ago
Positive Outlook for Unicycive Therapeutics Amidst Promising Developments and Financial Stability
Premium
Ratings
Positive Outlook for Unicycive Therapeutics Amidst Promising Developments and Financial Stability
5M ago
Unicycive Therapeutics reports Q3 EPS (46c), consensus (53c)
Premium
The Fly
Unicycive Therapeutics reports Q3 EPS (46c), consensus (53c)
6M ago
Unicycive Therapeutics price target raised to $22 from $9 at H.C. Wainwright
PremiumThe FlyUnicycive Therapeutics price target raised to $22 from $9 at H.C. Wainwright
6M ago
Unicycive Therapeutics Updates FDA Application for OLC
Premium
Company Announcements
Unicycive Therapeutics Updates FDA Application for OLC
6M ago
Unicycive provides update on meeting with FDA, resubmission of NDA for OLC
Premium
The Fly
Unicycive provides update on meeting with FDA, resubmission of NDA for OLC
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100